Search Results

There are 5737 results for: content related to: Carvedilol for preventing recurrent variceal bleeding: Waiting for convincing evidence

  1. Evaluation of Carvedilol for the Treatment of Portal Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 1, January 2004, Pages: 94–104, Brian A. Hemstreet

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.24.1.94.34805

  2. You have free access to this content
    Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis

    Hepatology

    Volume 36, Issue 6, December 2002, Pages: 1367–1373, Rafael Bañares, Eduardo Moitinho, Ana Matilla, Juan Carlos García-Pagán, José Luis Lampreave, Carlos Piera, Juan G. Abraldes, Alejandro De Diego, Agustín Albillos and Jaime Bosch

    Article first published online : 7 MAR 2007, DOI: 10.1002/hep.1840360612

  3. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 6, March 2014, Pages: 557–568, E. Sinagra, G. Perricone, M. D'Amico, F. Tinè and G. D'Amico

    Article first published online : 26 JAN 2014, DOI: 10.1111/apt.12634

  4. You have free access to this content
    Beta-blockers in portal hypertension: new developments and controversies

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 655–667, Dhiraj Tripathi and Peter C. Hayes

    Article first published online : 20 NOV 2013, DOI: 10.1111/liv.12360

  5. You have free access to this content
    Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 825–833, Dhiraj Tripathi, James W. Ferguson, Narendra Kochar, Joanna A. Leithead, George Therapondos, Norma C. Mcavoy, Adrian J. Stanley, Ewan H. Forrest, William S. Hislop, Peter R. Mills and Peter C. Hayes

    Article first published online : 24 APR 2009, DOI: 10.1002/hep.23045

  6. You have free access to this content
    Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

    Hepatology

    Volume 30, Issue 1, July 1999, Pages: 79–83, Rafael Bañares, Eduardo Moitinho, Belén Piqueras, Marta Casado, Juan-Carlos García-Pagán, Alejandro de Diego and Jaume Bosch

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510300124

  7. Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

    Cardiovascular Drug Reviews

    Volume 10, Issue 2, June 1992, Pages: 127–157, Robert R. Ruffolo Jr., Duane A. Boyle, David P. Brooks, Giora Z. Feuerstein, Robert P. Venuti, Mary Ann Lukas and George Poste

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1992.tb00242.x

  8. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue 2, February 2002, Pages: 183–189, BINAY K DE, DEBASISH DAS, SAMBIT SEN, PRANAB K BISWAS, SANJAY K MANDAL, DEBASIS MAJUMDAR and AJIT K MAITY

    Article first published online : 23 NOV 2002, DOI: 10.1046/j.1440-1746.2002.02674.x

  9. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 11, November 2012, Pages: 1681–1687, Gin-Ho Lo, Wen-Chi Chen, Huay-Min Wang and Hsien-Chung Yu

    Article first published online : 29 OCT 2012, DOI: 10.1111/j.1440-1746.2012.07244.x

  10. Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 2, February 2015, Pages: 202–212, Da Liu, Ying Huang, Bin Li, Changqing Jia, Feng Liang and Qin Fu

    Article first published online : 12 JAN 2015, DOI: 10.1111/1440-1681.12345

  11. Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry

    Chirality

    Volume 24, Issue 3, March 2012, Pages: 209–214, Josiane Cristófani Poggi, Flávia Garcez Da Silva, Eduardo Barbosa Coelho, Maria Paula Marques, Carlo Bertucci and Vera Lucia Lanchote

    Article first published online : 24 JAN 2012, DOI: 10.1002/chir.21984

  12. Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation

    British Journal of Pharmacology

    Volume 171, Issue 23, December 2014, Pages: 5182–5194, J Kisselbach, C Seyler, P A Schweizer, R Gerstberger, R Becker, H A Katus and D Thomas

    Article first published online : 28 AUG 2014, DOI: 10.1111/bph.12596

  13. Carvedilol: A Novel Multiple Action Antihypertensive Drug that Provides Major Organ Protection

    Cardiovascular Drug Reviews

    Volume 12, Issue 2, June 1994, Pages: 85–104, Giora Feuerstein, Tian-Li Yue, XinLiang Ma and Robert Ruffolo Jr.

    Article first published online : 2 APR 2007, DOI: 10.1111/j.1527-3466.1994.tb00285.x

  14. Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 6–24, Dr Brian F. McBride and Dr C. Michael White

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004269841

  15. Mechanism of carvedilol-induced block of delayed rectifier K+ current in the NG108-15 neuronal cell line

    Drug Development Research

    Volume 58, Issue 2, February 2003, Pages: 196–208, Chun-Peng Liu, Hung-Ting Chiang, Chung-Ren Jan and Sheng-Nan Wu

    Article first published online : 27 MAR 2003, DOI: 10.1002/ddr.10165

  16. You have free access to this content
    Oxidative Status, Inflammation, and Postoperative Atrial Fibrillation With Metoprolol vs Carvedilol or Carvedilol Plus N-Acetyl Cysteine Treatment

    Clinical Cardiology

    Volume 37, Issue 5, May 2014, Pages: 300–306, Mehmet Ozaydin, Oktay Peker, Dogan Erdogan, Selahaddin Akcay, Habil Yucel, Atilla Icli, Betul M. Ceyhan, Recep Sutcu, Bayram A. Uysal, Ercan Varol, Abdullah Dogan and Huseyin Okutan

    Article first published online : 29 JAN 2014, DOI: 10.1002/clc.22249

  17. You have free access to this content
    Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction

    Clinical Cardiology

    Volume 28, Issue 4, April 2005, Pages: 165–173, Gerald V. Naccarelli and Mary Ann Lukas

    Article first published online : 5 DEC 2006, DOI: 10.1002/clc.4960280403

  18. You have free access to this content
    Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 1099–1110, K Staudacher, I Staudacher, E Ficker, C Seyler, J Gierten, J Kisselbach, A-K Rahm, K Trappe, PA Schweizer, R Becker, HA Katus and D Thomas

    Article first published online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01319.x

  19. You have free access to this content
    Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential

    Cardiovascular Drug Reviews

    Volume 19, Issue 2, June 2001, Pages: 152–171, Jianhua Cheng, Kaichiro Kamiya and Itsuo Kodama

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2001.tb00061.x

  20. Enantioselective pharmacokinetic–pharmacodynamic modelling of carvedilol in a NG-nitro-l-arginine methyl ester rat model of secondary hypertension

    Journal of Pharmacy and Pharmacology

    Volume 62, Issue 7, July 2010, Pages: 890–900, Carla Andrea Di Verniero, Facundo Bertera, Fabián Buontempo, Ezequiel Bernabeu, Diego Chiappetta, Marcos Alejandro Mayer, Guillermo Federico Bramuglia, Carlos Alberto Taira and Christian Höcht

    Article first published online : 29 JUN 2010, DOI: 10.1211/jpp.62.07.0010